Namwiwat Medical Corporation Future Growth
Future criteria checks 3/6
Namwiwat Medical is forecast to grow earnings and revenue by 16.9% and 12.3% per annum respectively. EPS is expected to grow by 14.2% per annum. Return on equity is forecast to be 13% in 3 years.
Key information
16.9%
Earnings growth rate
14.2%
EPS growth rate
| Medical Equipment earnings growth | 22.3% |
| Revenue growth rate | 12.3% |
| Future return on equity | 13.0% |
| Analyst coverage | Low |
| Last updated | 15 May 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,440 | 276 | -11 | 284 | 1 |
| 12/31/2025 | 1,309 | 241 | 36 | 329 | 1 |
| 12/31/2024 | 1,190 | 212 | -34 | 212 | 1 |
| 3/31/2024 | 1,007 | 168 | 77 | 135 | N/A |
| 12/31/2023 | 1,103 | 201 | 220 | 259 | N/A |
| 9/30/2023 | 1,239 | 242 | 149 | 158 | N/A |
| 12/31/2022 | 1,100 | 176 | -135 | -81 | N/A |
| 12/31/2021 | 995 | 175 | 93 | 94 | N/A |
| 12/31/2020 | 679 | 112 | 104 | 105 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NAM-F's forecast earnings growth (16.9% per year) is above the savings rate (1.9%).
Earnings vs Market: NAM-F's earnings (16.9% per year) are forecast to grow faster than the TH market (15.1% per year).
High Growth Earnings: NAM-F's earnings are forecast to grow, but not significantly.
Revenue vs Market: NAM-F's revenue (12.3% per year) is forecast to grow faster than the TH market (6.6% per year).
High Growth Revenue: NAM-F's revenue (12.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: NAM-F's Return on Equity is forecast to be low in 3 years time (13%).